SHANGHAI JUNSHI BIO YC1 Cash Flow-to-Debt Ratio
SHANGHAI JUNSHI BIO YC1 cash flow-to-debt ratio. SHANGHAI JUNSHI BIO YC1 (8SJ) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of €-514.51 Million could theoretically repay 0% of its total liabilities (€6.33 Billion) in one year. See 8SJ free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SHANGHAI JUNSHI BIO YC1 (2021–2025)
Cash flow-to-debt ratio of SHANGHAI JUNSHI BIO YC1 from 2021 to 2025. Historical debt coverage capacity for SHANGHAI JUNSHI BIO YC1 across 5 annual periods. Also explore SHANGHAI JUNSHI BIO YC1 (8SJ) net asset momentum to track the company's year-over-year net asset growth rate.
SHANGHAI JUNSHI BIO YC1 Cash Flow-to-Debt Ratio by Year (2021–2025)
SHANGHAI JUNSHI BIO YC1 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for SHANGHAI JUNSHI BIO YC1. For the full cash flow conversion analysis, see SHANGHAI JUNSHI BIO YC1 (8SJ) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | €-514.51 Million | €6.33 Billion | ▲ +72.7% |
| 2024 | -0.30x | €-1.44 Billion | €4.85 Billion | ▲ +40.6% |
| 2023 | -0.50x | €-2.01 Billion | €4.02 Billion | ▲ +21.5% |
| 2022 | -0.64x | €-1.78 Billion | €2.78 Billion | ▼ -170.3% |
| 2021 | -0.24x | €-641.90 Million | €2.72 Billion | — |